Pharmacokinetic Study of ASP1517 With Kremezin®

NCT02693613 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ASP1517
DRUG: Kremezin®

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]